Spain updates vaccination groups for people down to the age of 45
The Ministry of Health has updated their vaccination plan in the battle against Covid-19 in Spain. They have officially established the vaccination order for the priority of the next groups, which are divided into age and type of vaccine. After the first groups are completed, will start to inoculate everyone by age group.
The plan includes the creation of five new groups, which are:
- people from 70 to 79 years (group 5B),
- people from 60 to 69 (group 5C),
- those under 60 with high risk conditions for severe Covid-19 (group 7)
- and those aged between 56 and 59 (group 8).
These will all be inoculated with doses of the Pfizer or Moderna vaccine (mRNA).
The fifth group is made up of people between 45 and 55 years of age (group 9), to whom the AstraZeneca vaccine will be administered, as soon as the vaccination has been completed of groups with essential jobs.
The document recalls that the main risk factor for hospitalization and death is in those over 60 years old, and that it increases as age gets older. For this reason, based on the “principles of necessity and equity,” older people who are not institutionalized should be vaccinated as soon as possible, says the Ministry of Health document.
The update also emphasizes that it is essential to consider the "principle of solidarity" so that vaccines that have proven efficacy in older age groups and the importance to reach these people, taking into account that all vaccines available in Spain are safe and effective.
In the same way, the immunization recommendations for people with previous coronavirus infection, both asymptomatic and symptomatic, are made official. In this way, these people will be inoculated when "they are fully recovered and the isolation period has ended." In the case of those under 55 years of age who have passed the infection symptomatically or asymptomatically, only one dose of vaccine will be administered six months after infection.
Other articles that may interest you...
In addition, the document prioritizes the right to inoculate a dose to a dependent person over the desire of his legal guardian. It clarifies that those "residents and large dependents" in which there are "several legal guardians" who do not agree with the vaccination, will be vaccinated. "The decision that science supports as the best option for these people, which is vaccination, will prevail, unless there is some clinical reason that justifies not doing so."
Another novelty is that the premise of "set dose, dose that counts" is marked. That is, if for reasons of shortage or the like, the administration of the second dose is delayed beyond the recommended interval, "the dose set is not invalidated", as it will continue to protect. Remember that the second dose will be administered as soon as possible after the recommended day (21 days, Pfizer; 28 days, Moderna, and preferably 12 weeks, in AstraZeneca’s case).